Trial Profile
A Phase 2 Study of Pre-Operative Ipilimumab and Cryoablation in Early Stage/Resectable Breast Cancer.
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 20 Aug 2014
Price :
$35
*
At a glance
- Drugs Ipilimumab (Primary)
- Indications Early breast cancer
- Focus Adverse reactions; Therapeutic Use
- 20 Aug 2014 New trial record